
Microplastics shed by food packaging are contaminating our food and drink, study finds
Food & health
Corporate news
PollutionFacebookTweetLink
Follow
Ripping the plastic wrap from the meat or prepackaged fruit and veggies you purchased at the grocery store may contaminate your food with micro- and nanoplastics, according to new research.
Plastic contamination may also occur when you're unwrapping deli meat and cheese, steeping a tea bag in hot water, or opening cartons of milk or orange juice. Glass bottles and jars with a plastic-coated metal closure may also shed microscopic bits of plastic, the study found.
In fact, the abrasion from repeatedly opening and closing the caps on glass and plastic bottles can release an untold amount of micro- and nanoplastics into the beverage, said Lisa Zimmermann, lead author of the study published Tuesday in the journal NPJ Science of Food.
'The research shows the number of microplastics increases with each bottle opening, so therefore we can say it's the usage of the food contact article which leads to micro- and nanoplastic release,' said Zimmermann, scientific communication officer at the Food Packaging Forum, a nonprofit foundation based in Zurich, Switzerland, that studies chemicals in food contact materials.
Researchers have measured micro- and nanoplastics in such food and drink products as beer, canned fish, rice, mineral water, tea bags, table salts, take-out foods and soft drinks, according to the study.
'This is the first systematic evidence of how normal and intended use of foodstuffs packaged in plastics can be contaminated with micro- and nanoplastics,' Zimmermann said. 'We found food packaging is actually a direct source of the micro- and nanoplastics measured in food.'
A separate investigation by the Food Packaging Forum published in September 2024 found more than 3,600 chemicals leach into consumer products during food manufacturing, processing, packaging and storage, ending up in the human body.
Seventy-nine of those food-processing chemicals are known to cause cancer, genetic mutations, endocrine and reproductive issues, and other health concerns, according to the September 2024 study.
And while scientists have long known about potentially toxic chemicals from plastics leaching into food, 'what's less clear, and deeply concerning, is just how significant food packaging is as a source of exposure to plastic particles and what that means for our health,' said David Andrews, acting chief science officer at the Environmental Working Group, a Washington, DC-based health and environmental advocacy organization, in an email.
'This new study highlights food packaging and processing equipment as potentially significant sources of microplastic contamination in the food we eat, and ultimately in our bodies,' said Andrews, who was not involved with the research. 'This study should raise alarm bells.'
CNN reached out to the Plastics Industry Association for comment but did not hear back before publication.
Microplastics are polymer fragments that can range from less than 0.2 inch (5 millimeters) down to 1/25,000th of an inch (1 micrometer). Anything smaller is a nanoplastic that must be measured in billionths of a meter.
At 1,000th the average width of a human hair, experts say nanoplastics are so teeny they can migrate through the tissues of the digestive tract or lungs into the bloodstream. As the blood circulates, the plastics may distribute potentially harmful synthetic chemicals throughout the body and into cells.
A flurry of recent studies have discovered microplastics and nanoplastics in human brain tissue, the testes and the penis, human blood, lung and liver tissues, urine and feces, mother's milk, and the placenta.
In the first analysis to illustrate harm to human health, a March 2024 study found people with microplastics or nanoplastics in their carotid artery tissues were twice as likely to have a heart attack or stroke or die from any cause over the next three years than people who had none.
The latest research searched thousands of studies to find those that did the best job of identifying and measuring plastics in tested foods before narrowing the list to 103 for the review.
Microplastic research is quite new, and studies so far often use different methods of microplastic identification and measurement. The lack of standard protocol can make it difficult to adequately compare findings, said senior study author Jane Muncke, managing director and chief scientific officer at the Food Packaging Forum.
'The novel aspect of our analysis is we didn't just collect all the studies, but we also examined the scientific reliability of their methods. We included a critical appraisal step,' Muncke said. 'That left us with seven highly reliable studies — more high-quality research is definitely needed.'
According to that research, ultraprocessed foods contain significantly more microplastics than minimally processed foods.
'There's a higher number of manufacturing steps with ultraprocessed foods, which can increase the contact time with plastic food processing equipment,' Muncke said, 'thus increasing the chance of micro- and nanoplastic migration.'
Migration into food also increased when the plastic packaging was heated, washed for reuse, exposed to sunlight and subjected to mechanical stress — such as the twist used to open a bottle cap, according to the review. That sort of repeated stress could lead to higher abrasion than opening a plastic container, so future research should consider how plastic is used as well as the types of plastics, Muncke said.
'This is a rigorous, detailed and critical study that applies robust systematic methods to review the existing literature on microplastics and food contact materials,' said Megan Deeney, a research fellow and doctoral student in plastics and global health at the London School of Hygiene & Tropical Medicine at the University of London, in an email.
'What is particularly important is that the authors take the time to extract and evaluate evidence on whether the presence of microplastics changed over time in these studies — this can help to identify the food contact material itself as a direct source of food contamination by microplastics,' said Deeney, who was not involved with the new research.
One of the studies included in the new review found 1 liter of water — the equivalent of two standard-size bottled waters bought at the store — contained an average of 240,000 plastic particles from seven types of plastics, of which 90% were identified as nanoplastics and the rest were microplastics.
Another example involved melamine, which is used to make bowls, plates, cups and other plastic tableware.
'In one study, researchers washed a melamine bowl 10 times, 20 times, 50 times, 100 times and measured the amount of microplastic it released each time,' Zimmermann said. 'Then they put something in the bowl and tested it and found more microplastic release after increased washing.'
While it's not yet possible to clean microplastics from the food supply, there are steps one can take to reduce exposure to plastics and the chemicals they secrete.
'One is to reduce our plastic footprint by using stainless steel and glass containers, when possible,' said Dr. Leonardo Trasande, director of environmental pediatrics at NYU Langone Health, in an earlier interview with CNN.
'Avoid microwaving food or beverages in plastic, including infant formula and pumped human milk, and don't put plastic in the dishwasher, because the heat can cause chemicals to leach out,' Trasande said.
In addition, check the recycling code on the bottom of packaging to find the plastic type, and avoid plastics with recycling code 3, which typically contain phthalates, he added.
Bring reusable bags to the grocery store, suggests the Natural Resources Defense Council, a New York City-based environmental advocacy group. Invest in a zippered fabric bag and ask the dry cleaner to return your clothes in that instead of those thin sheets of plastic. Bring a travel mug to the local coffee store for takeout and silverware to the office, cutting back on plastic cups and utensils.
However, due to the pervasiveness of microplastics in the environment, 'this is not something that any individual can solve on their own,' Deeney said.
'We need systemic action to reduce plastics production and pollution,' she said via email, encouraging anyone concerned about the issue to send a message to their representatives.
'There's a critical opportunity for individuals to engage with governments to demand strong, ambitious action on plastics in the upcoming final round of negotiations for a Global Plastics Treaty in Geneva this August, where more than 175 countries will convene to determine a legally-binding instrument to end plastics pollution.'
Get inspired by a weekly roundup on living well, made simple. Sign up for CNN's Life, But Better newsletter for information and tools designed to improve your well-being.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Multiple bodies found with hands, feet tied in Mediterranean Sea
Spanish authorities have launched an investigation after discovering multiple corpses in the Mediterranean Sea whose hands and feet had been tied, police said on Monday. According to regional daily Diario de Mallorca, since mid-May Civil Guard boats have spotted at least five bodies with their feet and hands bound. Police suspect that the victims may be migrants from North Africa, the Majorca Daily Bulletin reported. Diario de Mallorca quoted investigators as saying that the migrants may have been tied up and thrown into the sea during the crossing, potentially due to a dispute with their smugglers. The investigation into suspected homicide aims to identify the victims and work out the causes of their death, a Civil Guard spokeswoman told AFP. The discovery shows "the cruelest side" of the irregular migration route, regional president Marga Prohens told local media. Although most of the tens of thousands of Europe-bound migrants Spain receives arrive via the Canary Islands in the Atlantic, hundreds attempt the shorter crossing from north Africa to the Balearic archipelago in the Mediterranean. Authorities said 31 bodies had been found in the waters and beaches of the archipelago between January and June of this year, the Majorca Daily Bulletin reported earlier this month. In 2023, the United Nation's International Organization for Migration recorded 8,542 migrant deaths around the world – with 37% of these deaths occurring in the Mediterranean. There have also been dramatic rescues in the region. Earlier this month, a charity ship rescued more than 50 migrants from an abandoned oil platform in the Mediterranean, where one woman gave birth, according to the Spain-based NGO Open Arms. And in January, the Spanish coastguard rescued a baby that was born on an inflatable vessel carrying migrants to the Canary Islands. Kidney dialysis industry accused of maximizing profits over patients Pentagon officials reveal new details about U.S. strikes on Iran's nuclear sites Extended interview: LQ Goldring on her quest for a kidney donor


Medscape
an hour ago
- Medscape
Pola-R-CHP May Reverse Outlook in High-Risk Lymphoma
LUGANO, Switzerland — Patients with diffuse large B-cell lymphoma (DLBCL) in a genetic subgroup associated with worse outcomes show significantly greater responses to treatment with the standard first-line regimen of polatuzumab vedotin plus R-CHOP (Pola-R-CHP) compared with R-CHOP alone, new research showed. 'We found that newly diagnosed patients with DLBclass [classifier]-defined C5 DLBCLs derive the greatest benefit from Pola-R-CHP therapy,' said first author Eleonora Calabretta, MD, of the Dana-Farber Cancer Institute in Boston , in presenting the late-breaking findings at the 18th International Conference on Malignant Lymphoma (ICML) 2025. 'These findings support the use of DLBclass to design molecularly driven clinical trials and inform practice.' The pivotal POLARIX trial, comparing the combination of the anti-CD79B drug polatuzumab and the long-time standard chemotherapy regimen of R-CHOP to R-CHOP alone, became the first phase 3 trial in more than 20 years to show a regimen to have greater efficacy over R-CHOP, with a 2-year progression-free survival (PFS) of 76.7% vs 70.2%, respectively, which was sustained at 5 years (66.7% vs 58.1%), placing Pola-R-CHP in position as a new standard of care in newly diagnosed patients with intermediate- to high-risk DLBCL. However, as evidence mounts showing a multitude of genetic subsets in DLBCL that may have varying responses to therapies, Calabretta and her colleagues conducted an analysis of the POLARIX trial to look at possible differences within that trial. For their analysis, the team's recently established DLBclass classifier, a probabilistic, neural network-based tool that categorizes patients in genetic clusters ranging from C1 through C5, was utilized. Tumor biopsies from 407 patients in the POLARIX trial were analyzed, including 198 who were treated with R-CHOP and 209 treated with Pola-R-CHP. Patients' baseline clinical characteristics were well balanced between treatment arms. The results showed a substantial difference between patients in the two treatment groups who were specifically in the C5 cluster, which is associated with the poorest outcomes of the five groups, characterized by recurrent MYD88 and CD79B gain-of-function mutations and enhanced B-cell receptor signaling. Among those patients, the 5-year PFS rate of those in the Pola-R-CHP group was 70.4% compared with just 42% in the R-CHOP arm (hazard ratio [HR], 0.38; P = .005). 'These findings are especially important if we consider that the cluster C5 patients are those with the poorest prognoses among all the subsets, suggesting that the Pola-containing regimen may abrogate the predicted poor outcomes of this particular subset,' Calabretta said. In contrast, all of the 5-year PFS outcomes in the four other molecular clusters (C1-C4) were comparable between the two treatment arms, she added. The improved benefit of Pola-R-CHP in the C5 group remained after a multivariate adjustment for factors including International Prognostic Index score (2 vs 3-5), age (60 years or older vs younger than 60 years), and cell of origin (activated B cell, germinal center B cell, or unclassified, unknown; HR 0.41; P = .012). The study further showed the Pola-R-CHP benefit in C5 DLBCL was independent of patients' CD79B mutational status, which is known to be prevalent in C5 DLBCL. While the results did not show a significant improvement in overall survival — consistent with the findings in the POLARIX primary results — Calabretta noted that there was a significant trend that was nevertheless promising. 'We do see a nonstatistically significant trend that is likely due to the fact that salvage therapies for patients that relapse have great efficacy and can rescue many patients,' she told Medscape Medical News . 'There are many novel therapies for patients that relapse, and this is quite exciting and unprecedented in DLBCL treatment history.' The DLBclass app is free and available for download. 'It does require processed sequencing data,' Calabretta said, 'but is available for use for anyone that would like to.' 'Our work has shown that DLBclass can identify patients that respond to Pola-R-CHP, but as of now in a research setting. There is ongoing effort to make this a clinically actionable assay,' she added. Classifiers Provide Granularity to DLBCL's High Molecular Heterogeneity As opposed to another genetic classifier tool, LymphGen, in which approximately 40% of cases were unclassified or in a composite category, the newer DLBclass classifier, described in May in the journal Blood , assigns all patients with detectable mutations to one of the five genetic clusters, regardless of the confidence level. Commenting on the study, Alvaro Alencar, MD, an associate professor of clinical medicine at the University of Miami Sylvester Comprehensive Cancer Center in Miami, noted the study has important 'clinical significance as it expands the understanding of the activity of Pola-R-CHP in different DLBCL subsets.' The study supports prior exploratory subgroup analyses of POLARIX that suggest greater benefit in patients with the ABC cell-of-origin, one of two main genetic subtypes previously identified (along with the GCB subtype), Alencar noted. 'We know C5 is enriched for the ABC [molecular subset], and the greater response in this class reinforces the previous knowledge of greater activity of Pola-R-CHP in the ABC vs GCB [subgroups],' he told Medscape Medical News . While the retrospective analysis is 'incredibly helpful, the next frontier is how to apply this on a large scale,' he noted. 'Not even the FISH [fluorescence in situ hybridization; chromosomal test) is uniformly performed in DLBCL worldwide,' he noted. 'If indeed available with fast turnaround time, [the DLBclass classifier] could help identify a subgroup that should be certainly preferably treated with Pola-R-CHP,' Alencar said. Molecular Classification in DLBCL Hits 'Prime Time' Discussing the DLBclass research, as well as a dizzying array of other studies at the meeting tackling the complex genetic heterogeneity of DLBCL, Martin Dreyling, MD, noted that many prior studies looking to improve upon the long-held standard of R-CHOP basically 'failed because we didn't see the whole picture.' Due to advances such as LymphGen, the DLBclass tool, and other emerging stratifying approaches, 'we now have more granular classification, and this will give us a more detailed view of the disease,' said Dreyling, a professor of medicine and head of the lymphoma program at the Department of Medicine III, LMU Hospital Munich, Munich, Germany, in a meeting overview. 'The key question is, what are the clinical consequences? That is what we have to explore,' he emphasized, noting that in the POLARIX analysis, 'we can see that Pola-R-CHP does have a major impact in the C5 subgroup.' The rapidly evolving research developments ultimately indicate that 'it's prime time in molecular classification,' Dreyling said.


Bloomberg
2 hours ago
- Bloomberg
Novo Seeks Deals to Reverse Slide in Weight-Loss Market It Made
Novo Nordisk A/S is hunting for more early-stage deals to pad its pipeline of next-generation obesity drugs, as the drugmaker struggles to fend off rivals in the burgeoning weight-loss market it helped pioneer. The Danish company is casting a wide net with an open checkbook, according to Ludovic Helfgott, who took over as Novo's chief of product and portfolio strategy this year. 'The level of curiosity of the new Novo is maybe more than what people are expecting,' he said in an interview Monday from the American Diabetes Association meeting in Chicago.